Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short acting soft mydriatics.

R H Hammer1, W Wu, J S Sastry

  • 1Center for Drug Design and Delivery, College of Pharmacy, J. Hillis Miller Health Center, University of Florida, Gainesville 32610.

Current Eye Research
|June 1, 1991
PubMed
Summary

Three novel soft drug analogs demonstrated effective mydriatic activity, comparable to atropine, but with significantly shorter durations. These new mydriatics show promise for ophthalmic procedures due to their rapid action and potentially reduced systemic effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in the design and development of soft drugs.

Die Pharmazie·2014
Same author

Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2.

Pharmaceutical research·2013
Same author

Improved Delivery Through Biological Membranes. XVII. A Site-Specific Chemical Delivery System as a Short-Acting Mydriatic Agent.

Pharmaceutical research·2013
Same author

Improved Delivery Through Biological Membranes. XXIV. Synthesis, in Vitro Studies, and in Vivo Characterization of Brain-Specific and Sustained Progestin Delivery Systems.

Pharmaceutical research·2013
Same author

The effects of delta1-cortienic acid on skin blanching, pharmacokinetics and stability of loteprednol etabonate.

Die Pharmazie·2012
Same author

Brain-targeted delivery of estrogens.

Reviews in the neurosciences·2011

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Drug Design

Background:

  • Mydriatic agents are crucial for ophthalmic examinations.
  • Current agents like atropine have prolonged effects.
  • Soft drug technology offers a strategy for controlled drug release and duration.

Purpose of the Study:

  • To evaluate the mydriatic activity and metabolic profile of three novel soft drug analogs of atropine.
  • To compare their efficacy and duration with existing mydriatics.
  • To assess their potential for ophthalmic applications.

Main Methods:

  • In vivo mydriatic activity testing in rabbit eyes.
  • In vitro metabolic stability studies using rat, rabbit, and human blood.
  • Analysis of metabolic products and pharmacokinetic parameters (AUC).

Related Experiment Videos

Main Results:

  • Soft drug analogs exhibited equieffective mydriatic activity compared to atropine and tropicamide.
  • These analogs demonstrated significantly shorter durations of action.
  • Metabolic studies confirmed predictable breakdown into inactive acidic metabolites, with varying stability across species.

Conclusions:

  • The developed soft mydriatics offer a promising alternative to current agents.
  • Their ultrashort durations and predictable metabolism suggest improved safety profiles.
  • Potential applications include ophthalmoscopy and other ocular procedures requiring short-acting anticholinergic mydriasis.